Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 36.30
-0.93 (-2.50%)
At close: Jul 10, 2025
Hamps Bio Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Operating Revenue | 66.69 | 64.75 | 55.78 | 53.41 | 38.22 | Upgrade |
Other Revenue | - | - | - | -0 | - | Upgrade |
| 66.69 | 64.75 | 55.78 | 53.4 | 38.22 | Upgrade | |
Revenue Growth (YoY) | 2.99% | 16.08% | 4.45% | 39.71% | -17.67% | Upgrade |
Cost of Revenue | 19.99 | 18.12 | 19.05 | 22.71 | 18.7 | Upgrade |
Gross Profit | 46.7 | 46.64 | 36.73 | 30.69 | 19.53 | Upgrade |
Selling, General & Admin | 18.95 | 20.56 | 18.06 | 16.99 | 12.97 | Upgrade |
Other Operating Expenses | 20.05 | 14.31 | 10.01 | 7.55 | 4.57 | Upgrade |
Operating Expenses | 42.77 | 38.9 | 31.46 | 27.79 | 20.83 | Upgrade |
Operating Income | 3.92 | 7.74 | 5.28 | 2.9 | -1.3 | Upgrade |
Interest Expense | -1.4 | -1.43 | -1.71 | -1.87 | -2.56 | Upgrade |
Interest & Investment Income | - | 0.07 | 0.03 | 0.03 | 0 | Upgrade |
Other Non Operating Income (Expenses) | 1.51 | -0.06 | -0.07 | -0.03 | -0.03 | Upgrade |
EBT Excluding Unusual Items | 4.04 | 6.31 | 3.53 | 1.04 | -3.89 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.01 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0 | Upgrade |
Other Unusual Items | - | 0.19 | 0.03 | 0.01 | - | Upgrade |
Pretax Income | 4.04 | 6.5 | 3.57 | 1.05 | -2.22 | Upgrade |
Income Tax Expense | 1.06 | 1.49 | -0.02 | -0.17 | 0.02 | Upgrade |
Net Income | 2.98 | 5.01 | 3.59 | 1.22 | -2.24 | Upgrade |
Net Income to Common | 2.98 | 5.01 | 3.59 | 1.22 | -2.24 | Upgrade |
Net Income Growth | -40.54% | 39.47% | 195.47% | - | - | Upgrade |
Shares Outstanding (Basic) | 4 | 3 | 3 | 3 | 2 | Upgrade |
Shares Outstanding (Diluted) | 4 | 3 | 3 | 3 | 2 | Upgrade |
Shares Change (YoY) | 48.25% | 10.35% | - | 11.50% | 50.00% | Upgrade |
EPS (Basic) | 0.68 | 1.70 | 1.34 | 0.45 | -0.93 | Upgrade |
EPS (Diluted) | 0.68 | 1.70 | 1.34 | 0.45 | -0.93 | Upgrade |
EPS Growth | -59.89% | 26.53% | 197.78% | - | - | Upgrade |
Free Cash Flow | -44.24 | -6.54 | 4 | 0.42 | - | Upgrade |
Free Cash Flow Per Share | -10.11 | -2.21 | 1.50 | 0.16 | - | Upgrade |
Gross Margin | 70.02% | 72.02% | 65.85% | 57.48% | 51.09% | Upgrade |
Operating Margin | 5.88% | 11.95% | 9.46% | 5.43% | -3.40% | Upgrade |
Profit Margin | 4.46% | 7.73% | 6.44% | 2.27% | -5.85% | Upgrade |
Free Cash Flow Margin | -66.34% | -10.09% | 7.18% | 0.78% | - | Upgrade |
EBITDA | 7.69 | 11.77 | 8.66 | 6.15 | 1.98 | Upgrade |
EBITDA Margin | 11.53% | 18.18% | 15.53% | 11.52% | 5.19% | Upgrade |
D&A For EBITDA | 3.77 | 4.04 | 3.39 | 3.25 | 3.28 | Upgrade |
EBIT | 3.92 | 7.74 | 5.28 | 2.9 | -1.3 | Upgrade |
EBIT Margin | 5.88% | 11.95% | 9.46% | 5.43% | -3.40% | Upgrade |
Effective Tax Rate | 26.27% | 22.96% | - | - | - | Upgrade |
Revenue as Reported | 68.2 | 65.01 | 55.85 | 53.45 | 39.9 | Upgrade |
Advertising Expenses | - | - | - | - | 0.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.